O pozici
At Intuitive, we are united behind our mission: we believe that minimally invasive care is life-enhancing care. Through ingenuity and intelligent technology, we expand the potential of physicians to heal without constraints.
As a pioneer and market leader in robotic-assisted surgery, we strive to foster an inclusive and diverse team, committed to making a difference. For more than 25 years, we have worked with hospitals and care teams around the world to help solve some of healthcare’s hardest challenges and advance what is possible.
Intuitive has been built by the efforts of great people from diverse backgrounds. We believe great ideas can come from anywhere—we strive to foster an inclusive culture built around diversity of thought and mutual respect. We lead with inclusion and empower our team members to do their best work as their most authentic selves.
Passionate people who want to make a difference drive our culture—our team members are grounded in integrity, have a strong capacity to learn, the energy to get things done, and bring diverse, real-world experiences to help us think in new ways. We actively invest in our team members to support their long-term growth so they can continue to advance our mission and achieve their highest potential.
Join a team committed to taking big leaps forward for a global community of healthcare professionals and their patients. Together, let’s advance the world of minimally invasive care.
Co budeš dělat
- Reporting to the Director of Evidence Strategy and Access, Europe, within the Medical Affairs team. You will collaborate closely with Sales, Global Access Value and Economics, Clinical Affair, Governmental affairs, Marketing and Finance teams to develop robust frameworks for the assessment and appraisal of endoluminal robotics‑assisted technologies.
- Define and lead the Market Access strategy in France and Benelux, including: Pricing and reimbursement strategy
- Health economics, value demonstration and clinical evidence generation
- Access pathway optimization
- Adapt and scale successful approaches across other European markets, demonstrating flexibility to contribute to cross-country initiatives and business needs.
- Market Access Strategy Leadership: Develop the market access strategy for the France-BENELUX cluster in line with the global market access strategy, for the products marketed within the cluster. Ensure a successful evaluation by the agencies responsible for HTA (Health Technology Assessment) across all countries in the cluster; Act as the point of contact for health authorities regarding HTA evalu
- Pricing & Reimbursement Excellence: Lead high-stakes pricing negotiations with authorities (e.g., CEPS). Ensure alignment between value proposition, clinical evidence, and pricing ambition . Provide strategic guidance on innovative funding approaches and access models
- External Stakeholder Engagement: Build and maintain high-level relationships with: Government authorities and payers, key opinion leaders and medical societies, patient associations and industry trade unions. Represent Intuitive in external forums and strategic discussions supporting access of Endoluminal portfolio. Drive Intuitive’s reputation as a trusted partner in healthcare transformation
- Patient Access & Care Pathway Innovation: Integrate real-world insights into Market Access strategies. Identify barriers across: Hospital settings, Outpatient / ambulatory care pathways. Develop pragmatic, patient-centered access solutions to improve adoption and outcomes. Support initiatives that enhance continuity of care and system efficiency from diagnosis to treatment
Koho hledáme
- Strong adaptability and willingness to support cross-country initiatives, enabling effective scaling of approaches across European markets.
- Field reimbursement experience in Hospital setting
- A degree in health economics, public health, life sciences, or a related field (a postgraduate qualification is a plus).
- At least 5+ years of relevant experience in market access, health economics, or reimbursement, ideally in the MedTech sector, though pharma backgrounds wil
